Device Trial Radar · NCT05897723
Fractional Radiofrequency for Reduction of Surgical Scar Formation
Last checked: Nov 20, 2026Latest source record: Mar 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
20
Planned (sponsor's estimate)
Start
Sep 1, 2023
Primary completion
May 31, 2025
Study completion Dec 31, 2025
Sponsor
- Lead sponsor
- Venus ConceptNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 9, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 21 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Safety and Efficacy of Fractional Radiofrequency for the Reduction of Surgical Scar Formation
Conditions
- Surgical Incision
Interventions
Fractional RadiofrequencyDevice
Fractional Radiofrequency (RF) delivering nano-fractional RF energy, causing fractional ablation and coagulation at the treatment site.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Independent blinded assessmentTime frame: 6-months after treatment
- Principle Investigator (PI) evaluation of the scar(s)Time frame: 3- and 6-months after treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UT Southwestern Medical Center, Department of Plastic Surgery
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.